enow.com Web Search

  1. Ad

    related to: low blood clotting proteins in humans treatment medications list pdf

Search results

  1. Results from the WOW.Com Content Network
  2. Hypoprothrombinemia - Wikipedia

    en.wikipedia.org/wiki/Hypoprothrombinemia

    Hypoprothrombinemia can be the result of a genetic defect, may be acquired as the result of another disease process, or may be an adverse effect of medication.For example, 5-10% of patients with systemic lupus erythematosus exhibit acquired hypoprothrombinemia due to the presence of autoantibodies which bind to prothrombin and remove it from the bloodstream (lupus anticoagulant ...

  3. Fresh frozen plasma - Wikipedia

    en.wikipedia.org/wiki/Fresh_frozen_plasma

    Fresh frozen plasma (FFP) is a blood product made from the liquid portion of whole blood. [3] It is used to treat conditions in which there are low blood clotting factors (INR > 1.5) or low levels of other blood proteins. [3] [1] It may also be used as the replacement fluid in plasma exchange.

  4. Factor VIII (medication) - Wikipedia

    en.wikipedia.org/wiki/Factor_VIII_(medication)

    Factor VIII, an essential blood coagulation protein, [12] is used as a medication to treat and prevent bleeding in people with hemophilia A and other causes of low factor VIII. [13] [14] Certain preparations may also be used in those with von Willebrand's disease. [14] It is given by slow injection into a vein. [13]

  5. VKORC1 - Wikipedia

    en.wikipedia.org/wiki/VKORC1

    The reduction of vitamin K epoxide is then responsible for the carboxylation of glutamic acid residues in some blood-clotting proteins, including factor VII, factor IX, and factor X. [5] [7] VKORC1 is of therapeutic interest both for its role in contributing to high interpatient variability in coumarin anticoagulant dose requirements and as a ...

  6. Thrombosis prevention - Wikipedia

    en.wikipedia.org/wiki/Thrombosis_prevention

    The treatments to prevent the formation of blood clots is balanced against the risk of bleeding. [5] One of the goals of blood clot prevention is to limit venous stasis as this is a significant risk factor for forming blood clots in the deep veins of the legs. [6] Venous stasis can occur during the long periods of not moving.

  7. $2.9 million gene therapy for severe hemophilia is approved ...

    www.aol.com/news/gene-therapy-severe-hemophilia...

    The IV therapy is a long-awaited alternative to current treatments, including weekly doses of a protein needed to help blood clot. Some patients take a newer, longer-acting biotech drug that ...

  8. Prothrombin complex concentrate - Wikipedia

    en.wikipedia.org/wiki/Prothrombin_complex...

    The package insert states that prothrombin complex concentrate is contraindicated in patients with disseminated intravascular coagulation, a pathological activation of coagulation, [24] because giving clotting factors would only further fuel this process. However, if the PCC is given because factor levels are low, it can restore normal coagulation.

  9. EU regulator backs use of Pfizer's gene therapy for rare ...

    www.aol.com/news/eu-regulator-recommends-pfizers...

    (Reuters) - The European Medicines Agency (EMA) has recommended the use of Pfizer's gene therapy for a rare bleeding disorder called hemophilia B, which typically requires regular infusions of a ...

  1. Ad

    related to: low blood clotting proteins in humans treatment medications list pdf